BioCentury
ARTICLE | Company News

Matritech, Sysmex Corp. deal

October 8, 2007 7:00 AM UTC

The partners ended a 2002 deal that granted Sysmex an exclusive, worldwide license to develop MZT's NMP179 cervical cancer technology for automated, non-slide-based laboratory instruments. The develop...